Abstract
DESCRIPTION
Emerging markets for Microfluidic Applications in Life science and In-Vitro
Diagnostics
OBJECTIVES OF THE REPORT
Microfluidics has entered the Life Sciences market as a key technology to
provide solution adapted to the market requirements.
The microfluidic device market is promising and should reach $4 Billion in
2016. Yole Développement follows innovations and key players in this
market for several years. This is a fast evolving market, starting its
structuration and consolidation phase. Combined analysis of the technologies,
key players, markets and requirements is essential to understand this market
dynamics.
Emerging Markets for Microfluidic Applications (EMMA 2011) report provides a
complete analysis of Microfluidic device markets and technologies. Based on a
accurate analysis of what happened over the last three years, this report
consolidates market data for 2008-2010 and provides forecasts for 2010-2016.
MARKET SEGMENTATION
It' s worth noting that there are several applications for Microfluidics
technologies in Life science fields but the boundaries are often blurred.
Based on a rigorous segmentation, Yole' s analysts have been able to gather all
the information necessary to understand market needs for each application.
EMMA 2011 report provides trends and key elements in term of technical and
commercial aspects in order to success in your Microfluidic Business.
It describes the following applications:
- General Dispensing
- Drug Delivery
- Accurate Dispensing
- Analytical Devices
- Clinical and veterinary diagnostics
- Point Of Care testing
- Industrial & environmental testing
- Pharmaceutical and life science
- Microreaction technology
Each of them are developed with market data, trends and drivers, keys players
and technologies used.
MICROFLUIDIC SUPPLY AND VALUE CHAIN
The microfluidic market enters a phase where many products move from
prototyping to production. Many new players entered the supply chain recently,
bringing in their expertise in the mass production of electronic devices and
modules. Will these players manage the challenge of reducing the production
costs and make disposable microfluidic devices accessible for the medical
market?
- MICROFLUIDIC SUPPLY CHAIN
The report describes the microfluidic supply chain, from R&D to
commercialization and distribution. It shows for each type of material the
main players and their role in the supply chain.
The analysis of the value chain provides an understanding of costs related to
the different manufacturing steps (included packaging and quality control) in
relation to the cost of the final product which includes reagent,
commercialization and distribution costs.
BENEFITS
KEY FEATURES OF THE REPORT
- Consolidation of 2008-2010 market data based on the top 150
microfluidic players results
- Analysis of the last 3 years market evolution and key events, such
as mergers & acquisitions, innovative product launch, found rising, patents...
- 2010-2016 Microfluidic device forecasts with a unique market
segmentation of the different applications.
- Detailed supply and value chain analysis putting in evidence the
value of material and structuring in the complete value chain.
WHO SHOULD BUY THIS REPORT?
- Microfluidic Fabs and system developers
- Assess the total accessible market of your company' s related microfluidic
- Identify technology trends, challenges & requirements for the different
market applications
- Diagnostic companies and OEM
- Understand the microfluidic manufacturing supply and value chain
- Assess the positioning of your product in this dynamic market
COMPANY CITED IN THE REPORT
AB SCIEX, Abaxis, Abbott, Advion Biosciences, AES Laboratoire , Agilent
Technologies, Bartels mikrotechnik, BD, Bertin Technologies, Biodiot,
BioFluidix, bioMerieux, Biosite, Boehringer Ingelheim, Burkert, Caliper Life
Sciences, Cellectricon, Cepheid, Cetoni , Cytoo, Dalsa, Danaher, Debiotech,
Dolomite, Eksigent Technologies, Epocal, Fluidigm, Fluigent, GE Novasensor,
Genewave, GeSim, Great Basin, Hamilton, Ikerlan, Illumina, IMM, Invitrogen,
Johnson & Johnson, Konica Minolta Opto, LabCyte, Life Technologies, Merlin
diagnostic, MicroCHIPS, Micronit, MicroParts, Nanostream, Ocusense, Pall
Genesystem, PerkinElmer, Philips, PositiveID Corporation, Qiagen, Raindance
Technologies, Roche Applied Science, Samsung, Scienion, Sensirion, Seyonic,
Shimadzu Biotech, Shrink Nanotechnologies, Siemens Medical Solutions, Sony
DADC, Sophion, Stmicroelectronics, Texas Instrument, Tokyo Electron, Vantix
Ltd, and many others...
ABOUT YOLE DÉVELOPPEMENT
Beginning in 1998 with Yole Développement, we have grown to become a
group of companies providing market research, technology analysis, strategy
consulting, media in addition to fi nance services. With a solid focus on
emerging applications using silicon and/or micro manufacturing Yole
Développement group has expanded to include more than 40 associates
worldwide covering MEMS, Microfluidics & Medical, Advanced Packaging, Compound
Semiconductors, Power Electronics, LED, and Photovoltaic. The group supports
companies, investors and R&D organizations worldwide to help them understand
markets and follow technology trends to develop their business.
REPORT OUTLINE
|
|
- Publication type: Technologies, Applications, Industry& Market Report
- Released date: Mid October
- Number of slides: 180+ Powerpoint slides
- Format: PDF
|
Table of Contents
1 - EXECUTIVE SUMMARY
2 - INTRODUCTION
3 - MICROFLUIDICS MARKET 2011-2016
- Market geographical distribution
- Impact of microfluidics
- Microfluidic applications
- Microfluidic components market value and forecast
- Compound Annual Growth Rates 2008-2010 and 2011-2016
4 - WHAT HAPPENED SINCE 2009?
- Microfluidics, a dynamic market
- Microfluidic Patents 2009-2011
- Market data versus EMMA2009 forecasts
5 - MICROFLUIDIC APPLICATIONS
- General Dispensing
- Drug Delivery
- Accurate Dispensing
- Analytical Devices
- Clinical and veterinary diagnostics
- Point Of Care testing
- Industrial and environmental testing
- Pharmaceutical and life science
- Microreaction technology
6 - MICROFLUIDIC TECHNOLOGIES
7 - MICROFLUIDIC SUPPLY CHAIN
8 - MICROFLUIDIC VALUE CHAIN
9 - SUMMARY AND CONCLUSIONS
